Dutch Pharma Stock News

Why ING Groep (ENXTAM:INGA) is on investors’ radar today ING Groep (ENXTAM:INGA) is back in focus after a stretch of strong share price performance, with recent returns over the past week, month and past 3 months prompting closer attention from income and value oriented investors. See our latest analysis for ING Groep. That recent 16.43% 3 month share price return sits alongside a 71.03% 1 year total shareholder return and a 332.75% 5 year total shareholder return, which suggests positive...

As we enter 2026, the European market is experiencing a notable upswing, with the pan-European STOXX Europe 600 Index reaching new highs and closing 2025 with its strongest yearly performance since 2021. Amidst this positive economic backdrop, investors are increasingly exploring diverse opportunities within the stock market. Penny stocks, though often seen as remnants of past trading eras, continue to offer intriguing possibilities for those seeking affordable investments with growth...

There wouldn't be many who think AMG Critical Materials N.V.'s ( AMS:AMG ) price-to-sales (or "P/S") ratio of 0.7x is...

With a price-to-earnings (or "P/E") ratio of 40.4x ASML Holding N.V. ( AMS:ASML ) may be sending very bearish signals...

In recent days, ASM International has been highlighted as a key supplier of advanced atomic layer deposition and epitaxy tools used in manufacturing cutting-edge AI and high-performance computing chips for leading global fabs. This renewed focus on its role in enabling the most advanced logic nodes and high-bandwidth memory underscores how central ASM International has become to next-generation semiconductor production ecosystems. We’ll now examine how ASM International’s heightened...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...

With its stock down 16% over the past three months, it is easy to disregard IMCD (AMS:IMCD). However, stock prices are...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

It is hard to get excited after looking at Randstad's (AMS:RAND) recent performance, when its stock has declined 12...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...

With a price-to-earnings (or "P/E") ratio of 8x Signify N.V. ( AMS:LIGHT ) may be sending very bullish signals at the...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...

We wouldn't blame Prosus N.V. ( AMS:PRX ) shareholders if they were a little worried about the fact that Jacobus Petrus...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...

Koninklijke BAM Groep nv's ( AMS:BAMNB ) price-to-earnings (or "P/E") ratio of 22.4x might make it look like a sell...

When close to half the companies in the Netherlands have price-to-earnings ratios (or "P/E's") below 16x, you may...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

If you are wondering whether ASML Holding is still worth buying after its huge run, or if you have missed the boat on this chip equipment giant, you are in the right place to unpack what the current price is really telling us. Despite a recent dip of 2.6% over the last week, ASML is still up 1.7% over the past month, 30.7% year to date, and 32.7% over the last year, which keeps expectations and risk perceptions running high. Those moves are happening against a backdrop of ongoing demand for...

Heineken Holding (ENXTAM:HEIO) has quietly outperformed the broader European consumer staples space over the past month, and that strength is starting to catch investors attention as they reassess its longer term track record. See our latest analysis for Heineken Holding. Zooming out, Heineken Holding’s roughly 6 percent year to date share price return and double digit 1 year total shareholder return suggest momentum is gradually rebuilding as investors warm to its earnings recovery story. If...

ING Groep recently reported that, as part of its previously announced €1.10 billion share buyback programme, it repurchased 2,017,765 shares between 8 and 12 December 2025, bringing total repurchases to 13,399,920 shares, or about 27.13% of the programme’s maximum value. The buyback, aimed at reducing ING’s share capital, highlights the bank’s ongoing focus on returning excess capital to shareholders alongside its broader digital and sustainable finance initiatives. We’ll now examine how...

Earlier in December 2025, Galapagos NV reported updated Phase 2 results from its ATALANTA-1 trial of CD19 CAR T-cell therapy GLPG5101 in heavily pretreated mantle cell lymphoma, showing very high response rates, durable outcomes at nine months, and an encouraging safety profile presented at the ASH Annual Meeting. Beyond efficacy, the trial also highlighted the feasibility of decentralized manufacturing, with most patients receiving a fresh GLPG5101 product within seven days of apheresis,...

NN Group N.V.'s ( AMS:NN ) price-to-earnings (or "P/E") ratio of 13.4x might make it look like a buy right now compared...